Hypnosis is gaining recognition as a valuable complementary therapy in oncology, helping cancer patients manage pain, nausea, anxiety, and treatment-related distress through mind-body modulation.
The Psychosocial Burden of Cancer
A cancer diagnosis imposes an immense psychosocial burden. Beyond the physical toll of the disease itself, patients face treatment side effects including chemotherapy-induced nausea and vomiting (CINV), radiation fatigue, neuropathic pain, anticipatory anxiety, and existential distress. Up to 40% of cancer patients meet criteria for a mood or anxiety disorder, and uncontrolled symptoms are associated with poorer treatment adherence and quality of life [1]. Hypnosis offers a drug-free, patient-empowering tool that addresses both the psychological and physiological dimensions of cancer care.
Hypnosis for Chemotherapy-Induced Nausea and Vomiting
Chemotherapy-induced nausea and vomiting remains one of the most feared side effects of cancer treatment, despite advances in antiemetic pharmacotherapy. Anticipatory nausea — which occurs before chemotherapy infusion — is particularly resistant to medication. A seminal randomised trial by Morrow and colleagues demonstrated that hypnosis was significantly more effective than standard care in reducing both anticipatory and post-treatment nausea in breast cancer patients undergoing chemotherapy [2]. Subsequent meta-analyses have confirmed that hypnosis reliably reduces CINV severity, with effect sizes comparable to or exceeding those of commonly prescribed antiemetics, and without side effects.
Pain Management in Cancer Care
Cancer-related pain affects approximately 55% of patients undergoing active treatment and 66% of those with advanced disease. Opioid analgesia remains the cornerstone of management but carries risks of tolerance, hyperalgesia, and constipation that compound suffering. Hypnotic interventions for cancer pain have been extensively studied. A meta-analysis of 18 studies found that hypnosis produced significant reductions in pain intensity and pain-related interference, with effects sustained at follow-up [3]. Neuroimaging studies suggest that hypnosis modulates activity in the descending pain modulatory system, enhancing endogenous opioid pathways and altering thalamic gating of nociceptive signals.
Reducing Anxiety and Procedural Distress
Cancer treatment involves numerous invasive procedures — biopsies, port placements, lumbar punctures, and radiation simulation — each a source of acute anxiety. Hypnosis prior to these procedures reduces state anxiety, physiological arousal (heart rate, blood pressure, cortisol), and subjective distress. In paediatric oncology, hypnosis is particularly well-established, with the Society of Pediatric Psychology listing it as a well-supported treatment for procedure-related pain and distress [4]. Children who learn self-hypnosis techniques report greater perceived control over their treatment experience and demonstrate reduced need for sedation during procedures.
Toward Integrative Oncology Practice
Leading cancer centres including Memorial Sloan Kettering, MD Anderson, and the Dana-Farber Cancer Institute now offer clinical hypnosis services as part of their integrative medicine programmes. The Society for Integrative Oncology includes hypnosis in its clinical practice guidelines for symptom management during breast cancer treatment [5]. Training pathways for oncology nurses and allied health professionals in brief hypnotic techniques are expanding. Patients who learn self-hypnosis report enduring benefits — not only during treatment but in their long-term psychological recovery, with reduced fear of recurrence and improved post-traumatic growth.
References
- Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. The Lancet Oncology., 12(2), 160–174. DOI: 10.1016/S1470-2045(11)70002-X
- Morrow, G. R., & Morrell, C. (1982). Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. New England Journal of Medicine., 307(24), 1476–1480. DOI: 10.1056/NEJM198212093072402
- Montgomery, G. H., Schnur, J. B., & Kravits, K. (2012). Hypnosis for cancer care: Over 200 years young. CA: A Cancer Journal for Clinicians., 63(1), 31–44. DOI: 10.3322/caac.21165
- Liossi, C., & Hatira, P. (1999). Clinical hypnosis versus cognitive behavioral training for pain management with pediatric cancer patients undergoing bone marrow aspirations. International Journal of Clinical and Experimental Hypnosis., 47(2), 104–116. DOI: 10.1080/00207149908410025
- Greenlee, H., DuPont-Reyes, M. J., Balneaves, L. G., Carlson, L. E., Cohen, M. R., Deng, G., … & Tripathy, D. (2017). Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA: A Cancer Journal for Clinicians., 67(3), 194–232. DOI: 10.3322/caac.21397